Moleculin Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	10	26	30	53	50	42	28	39	27	-	-
Market Cap Growth	-	-15.67%	-42.91%	6.75%	18.99%	48.31%	-28.23%	43.03%	-	-	-
Enterprise Value	-13	3	-12	-18	35	31	21	32	23	0	1
PE Ratio	-0.86	-0.86	-1.04	-3.34	-2.87	-3.17	-2.38	-4.01	-7.00	-	-
PB Ratio	0.38	0.98	0.58	0.67	2.80	2.69	1.98	2.30	1.84	-	-
P/FCF Ratio	-1.06	-1.06	-1.10	-2.80	-2.74	-2.43	-2.24	-5.35	-7.26	-	-
P/OCF Ratio	-1.06	-1.06	-1.10	-2.80	-2.80	-2.43	-2.31	-5.37	-7.30	-	-
EV/EBITDA Ratio	-0.08	-0.08	0.43	1.12	-2.03	-2.37	-1.79	-3.23	-5.87	4.43	-0.67
EV/EBIT Ratio	-0.08	-0.08	0.43	1.11	-2.00	-2.34	-1.78	-3.22	-5.87	5.03	-0.67
EV/FCF Ratio	-0.10	-0.10	0.45	0.93	-1.92	-1.82	-1.67	-4.30	-6.02	-0.58	-0.81
Debt / Equity Ratio	0.02	0.02	0.01	0.00	0.01	0.02	-	-	0.02	-0.60	-0.66
Debt / EBITDA Ratio	-0.02	-0.02	-0.01	0.00	-0.01	-0.02	-	-	-0.08	4.73	-0.99
Debt / FCF Ratio	-0.02	-0.02	-0.01	0.00	-0.01	-0.02	-	-	-0.08	-0.62	-1.20
Quick Ratio	3.46	3.46	8.95	19.58	5.20	3.01	1.84	3.48	3.72	0.04	0.47
Current Ratio	3.86	3.86	9.46	20.02	5.89	3.78	2.06	3.75	3.88	0.04	0.33
Interest Coverage	-	-	-	-	-	-	-	-	-90.30	0.19	-10.27
Return on Equity (ROE)	-80.90%	-80.90%	-46.50%	-19.10%	-109.90%	-74.10%	-71.40%	-55.10%	-32.70%	22.80%	-
Return on Assets (ROA)	-67.70%	-67.70%	-42.20%	-17.40%	-61.40%	-48.60%	-53.10%	-48.00%	-29.60%	-90.40%	-
Return on Capital (ROIC)	-111.62%	-111.62%	-58.33%	-29.05%	-110.17%	-110.58%	-105.28%	-50.55%	-25.45%	157.91%	196.26%
Earnings Yield	-303.39%	-116.33%	-95.65%	-29.90%	-34.86%	-31.56%	-42.09%	-24.94%	-14.28%	-	-
FCF Yield	-246.89%	-94.67%	-91.30%	-35.69%	-36.44%	-41.22%	-44.73%	-18.70%	-13.77%	-	-
Buyback Yield / Dilution	-3.60%	-3.60%	-6.43%	-172.97%	-45.07%	-57.20%	-39.50%	-88.95%	-48.76%	-	-
Total Shareholder Return	-3.60%	-3.60%	-6.43%	-172.97%	-45.07%	-57.20%	-39.50%	-88.95%	-48.76%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).